Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
Treatment of multiple sclerosis with anti-CD20 antibodies.
[Plasmapheresis in central nervous system disorders].
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
Generic Midamor
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Puma, but not noxa is essential for oligodendroglial cell death.
Double blind placebo-controlled Phase I/II clinical trial of idebenone in patients with primary progressive multiple sclerosis (IPPoMS)
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis.

Pages